Blog Articles
Explore our articles
a department of MediStem Panama. The sponsor had the responsibility of initiating
managing
View Articlethe trends observed in this study are indicative of potential therapeutic benefits
reflected in lower CARS and ATEC scores that may be associated with decreases in TARC and MDC levels.
View Articlewhich impacted the statistical power of the analyses. Although a sample size of 20 subjects was still within FDA guidelines for phase I clinical trials
measurements at all time points were not completed by all participants
View Articleand MSCs have anti‐inflammatory and immune‐regulating properties that made them an interesting option to treat ASD symptoms. With this study
we have established that repeated infusions with UC MSCs are safe
View Articlepreclinical studies have reported that repeated doses of MSCs are more beneficial than a single dose for the treatment of other conditions49-51. Repeated dosage has consequently been proposed as a new paradigm in stem cell therapy52
53 and has been applied for other medical conditions15
View Article